SeroTracker
Your Go-To Source for COVID-19, MERS, and Arbovirus Seroprevalence Data
We synthesize findings from thousands of SARS-CoV-2 (COVID-19 virus), MERS (Middle East Respiratory Syndrome coronavirus), and Arbovirus seroprevalence studies worldwide. Seroprevalence studies are population-based studies that test for antibodies in blood or serum samples. Serological research studies help public health professionals and the public understand underlying rates of infection that may have been missed by routine testing, indicators of exposure and humoral immunity in risk groups, and can also help inform vaccination strategies. In some of our dashboards, i.e. MERSTracker, we also collect data on viral prevalence studies, and include research in multiple species.
We conduct regularly updated systematic reviews to comprehensively track existing research results around the world. We collect and standardize the data we extract from these studies, provide useful analytics on the data, and share insights relating to trends and patterns on our interactive, centralized, and open-access dashboards.
Check our dashboards using the buttons to the right or view our short tutorial on how to use our ArboTracker dashboard! See our About tab for more information our data, protocols, team, and how to cite us.
You can find our original SARS-CoV-2 tracker at
https://serotracker.comWe have data from 4,682 seroprevalence studies in 148 countries and territories including 38,389,552 participants across our three dashboards
MAP DISCLAIMER
The designations employed and the presentation of the material available on this platform does not imply the expression of any opinion whatsoever on the part of WHO, SeroTracker, or SeroTracker's partners concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.